BIO Bio-Rad Laboratories Inc. - Ordinary Shares - Class A
967
$293.85
$1.88
(0.64%)
| Watchers | 967 |
| 52-Wk Low | $261.59 |
| 52-Wk High | $431.79 |
| Market Cap | $8.43B |
| Volume | 189,761.00 |
| 52-Wk High | $431.79 |
| 52-Wk Low | $261.59 |
Bio-Rad Reports First-Quarter 2024 Financial ResultsBusiness Wire • 11 days ago
Bio-Rad Laboratories, Inc. (NYSE: BIO and BIO.B), a global leader in life science research and clinical diagnostics products, today announced financial results for the first quarter ended March 31...
Share to Feed
Top Five Cancer Types Dominate New US Cases as Biotech Sector Eyes $314B Market by 2032 Top Five Cancer Types Dominate New US Cases as Biotech Sector Eyes $314B Market by 2032 PR Newswire VANCOUVER...
Bio-Rad Laboratories, Inc. (NYSE: BIO and BIO.B), a global leader in life science research and clinical diagnostics products, today announced that its Chief Operating Officer Andy Last and Chief...
Bio-Rad Laboratories, Inc. (NYSE: BIO and BIO.B), a global leader in life science research and clinical diagnostics products, today announced the promotion of James J. Barry, currently Senior Vice...
Bio-Rad Laboratories, Inc. (NYSE: BIO and BIO.B), a global leader in life science research and clinical diagnostics products, will report its financial results for the first quarter of 2024 on...
Bio-Rad Laboratories, Inc. (NYSE: BIO and BIO.B), a global leader in life science research and clinical diagnostics products, today announced that Dr. Andrew Last, Executive Vice President and Chief...
Bio-Rad Laboratories, Inc. (NYSE:BIO - Free Report) - Zacks Research decreased their Q2 2024 earnings per share (EPS) estimates for shares of Bio-Rad Laboratories in a research report issued to...
In trading on Monday, shares of Bio-Rad Laboratories Inc (BIO) crossed below their 200 day moving average of 344.66, changing hands as low as 337.23 per share. Bio-Rad Laboratories Inc...
In this article, we will be taking a look at the 25 countries with highest malaria death rates. If you do not want to learn about the global malaria diagnostics market, head straight to the 5...
A month has gone by since the last earnings report for Perrigo (PRGO). Shares have added about 19.1% in that time frame, outperforming the S&P 500.Will the recent positive trend continue leading up...